Blog Reports
Check DailyStock reports by date and topic.
-
![[KOSDAQ Story] Samchundang Pharm (000250) Oral Keytruda Controversy and the Future: Scenarios for Verifying the S-PASS Platform](https://daily-stock.kr/stdaily/uploads/202606/gen_6a3f835b481484.29078336.png)
[KOSDAQ Story] Samchundang Pharm (000250) Oral Keytruda Controversy and the Future: Scenarios for Verifying the S-PASS Platform
Samchundang Pharm 000250 faces controversy over its proposed oral Keytruda using the S PASS platform after Merck denied any discussions. With its stoc...
-
![[S&P Story] The Lonely Leader in a $720 Billion Capex War: Microsoft's (MSFT) 21x P/E Reflects the Cold Reality and Warm Passion of the AI Capex Cycle](https://daily-stock.kr/stdaily/uploads/202606/gen_6a3f210257c1b4.72552454.png)
[S&P Story] The Lonely Leader in a $720 Billion Capex War: Microsoft's (MSFT) 21x P/E Reflects the Cold Reality and Warm Passion of the AI Capex Cycle
Microsoft's valuation reaches a 3 year low of ~21x Forward P/E amid high capital expenditures. While AI run rate hit $37B and Azure grew 40%, heavy Ca...
-
![[Nasdaq Story] Broadcom (AVGO) - OpenAI Reveal 'Jalapeño' and Collaborate with Alphabet (GOOGL) TPU: The Golden Age of Proprietary AI ASICs and Valuation Analysis](https://daily-stock.kr/stdaily/uploads/202606/gen_6a3f138fc8cb89.13142528.png)
[Nasdaq Story] Broadcom (AVGO) - OpenAI Reveal 'Jalapeño' and Collaborate with Alphabet (GOOGL) TPU: The Golden Age of Proprietary AI ASICs and Valuation Analysis
As the intelligence era begins in earnest, big tech companies' battle for semiconductor independence is crossing a critical threshold.
-
![[Global Markets] Eurozone PMI Rebounds to 49.5 and ECB's Surprise Rate Hike to 2.25%: 'Stagflation Defense' Scenario Amid US-EU-Asia Tri-Polar Decoupling](https://daily-stock.kr/stdaily/uploads/202606/gen_6a3ecc877b5e01.20880194.png)
[Global Markets] Eurozone PMI Rebounds to 49.5 and ECB's Surprise Rate Hike to 2.25%: 'Stagflation Defense' Scenario Amid US-EU-Asia Tri-Polar Decoupling
Daily Stock delivers the latest global financial trends. Eurozone's June Composite PMI rebounded to 49.5, while the ECB unexpectedly raised interest r...
-
![[KOSDAQ Story] 2026 H2 Bio Clinical Calendar: Major Momentum Check on LigaChem Biosciences, ABL Bio, Peptron, and More](https://daily-stock.kr/stdaily/uploads/202606/gen_6a3e31e7463827.12445472.png)
[KOSDAQ Story] 2026 H2 Bio Clinical Calendar: Major Momentum Check on LigaChem Biosciences, ABL Bio, Peptron, and More
As KOSDAQ fluctuates, the spotlight is on the H2 2026 clinical timelines and pipeline momentum of leading biotech firms including LigaChem Biosciences...
-
![[KOSPI Story] Imminent June Semi-Annual Ex-Dividend Date: Arbitrage Scenario Analysis Amid Foreign and Institutional Futures-Linked Supply-Demand Patterns and High-Dividend ETF Weakness](https://daily-stock.kr/stdaily/uploads/202606/gen_6a3e23f38f2426.41822396.png)
[KOSPI Story] Imminent June Semi-Annual Ex-Dividend Date: Arbitrage Scenario Analysis Amid Foreign and Institutional Futures-Linked Supply-Demand Patterns and High-Dividend ETF Weakness
On June 26, 2026, the KOSPI closed at 8,411.21. Investors are analyzing institutional arbitrage trading scenarios and foreign futures linked supply de...